CW April 2000

category image Volume 9
Issue Number 4
April 2000
ISSN 10593802

Innovative Palliative Treatment for Advanced Prostate Cancer

A novel implant to supply a constant level of testosterone-suppressing drug to advanced prostate cancer patients is approved by the US Food and Drug Administration. Bayer Corporation based in Pittsburgh, PA will distribute the implant.
Go to Previous Page
Go to Next Page

Purchase Downloadable Full-text PDF of Article: $10.00

Subscription is more cost effective than purchasing PDFs on-the-fly.  Click here for details.

Download Complete Issue CW April 2000

Purchase Downloadable Full-text PDF of Complete Issue: $20.00


Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us

Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA
phone: 518-456-0784; fax: 518-452-4955; email: info@adeninepress.com
copyright © Adeninepress, All rights reserved.




Re-initialize IP-based Login